Skip to content

Effects of different doses of remimazolam on early postoperative cognitive function in elderly patients undergoing laparoscopic radical resection of colorectal cancer

Effects of different doses of remimazolam on early postoperative cognitive function in elderly patients undergoing laparoscopic radical resection of colorectal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083122
Enrollment
Unknown
Registered
2024-04-16
Start date
2024-04-17
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Remimazolam group1:Infusion of remimazolam tosylate at a rate of 0.5mg/kg/h, remifentanil at a rate of 0.05-0.2ug/kg/min, and propofol at a rate of 1-10mg/kg/h throughout the surgery.
Remimazolam group2:Infusion of remimazolam tosylate at a rate of 1mg/kg/h, remifentanil at a rate of 0.05-0.2ug/kg/min, and propofol at a rate of 1-10mg/kg/h throughout the surgery.
Remimazolam group3:Infusion of remimazolam tosylate at a rate of 1.5mg/kg/h, remifentanil at a rate of 0.05-0.2ug/kg/min, and propofol at a rate of 1-10mg/kg/h throughout the surgery.
Propofol group:Infusion of remifentanil at a rate of 0.05-0.2ug/kg/min, and propofol at a rate of 1-10mg/kg/h throughout the surgery.

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective general anesthesia for laparoscopic radical resection of colorectal cancer in the elderly, regardless of gender. 2.ASA: Grade II-III; 3.Age: =65 years old; 4.Able to independently complete the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MOCA)

Exclusion criteria

Exclusion criteria: 1.Patients with a long history of alcohol consumption, neurological, muscular, endocrine system, or mental disorder history, or those who have been using neuro-psychoactive drugs such as anti-depressants and anti-anxiety medications for a long time; 2.Patients with severe impairment in cardiovascular, respiratory, liver, and kidney functions; 3.Patients with a body mass index below 18.5 kg/? or above 30 kg/?; 4.Patients who are unable to complete a mental function test successfully before surgery.

Design outcomes

Primary

MeasureTime frame
Mini-Mental State Examination;Montreal Cognitive Assessment;The incidence of POCD;

Secondary

MeasureTime frame
Systolic Blood Pressure;Diastolic blood pressure;Mean arterial pressure;Heartrate;The dosage of remifentanil used during surgery;The dosage of propofol used during surgery;Anesthesia recovery indicators;The occurrence of adverse events within 48 h postoperatively;VisualAnalogueScale/Score,VAS;Extubation and PACU residence times;The incidence of intraoperative hypotension;Postoperative sleep condition;

Countries

China

Contacts

Public ContactYong Pang

Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College

7821602@qq.com+86 158 0817 9936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026